Guinea-Bissau

in page functions
[French]
Guinea-Bissau
Total population (2018) 1,977,644
Birth cohort (2018) 69,475
Surviving Infants (surviving to 1 year per year, 2018) 63,818
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 60/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 93/1000
World Bank Index, IDA (2015) 2.48
Gross Nation Income (per capita US$, 2015) 590
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 11

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Guinea-Bissau

Type of support

Approvals

2001-2023 (US$)
(28 Nov 2018)

Commitments

2001-2023 (US$)
(28 Nov 2018)

Disbursements

2000-2018 (US$)
(28 Nov 2018)

% Disbursed

(28 Nov 2018)
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $13,321,784 $15,386,784 $12,613,861
Health system strengthening (HSS 1) $1,420,119 $1,420,119 $1,420,119 100%
Immunisation services support (ISS) $500,360 $500,360 $500,360 100%
Injection Safety Devices (NVS) $86,500 $130,500 $52,579 61%
Injection safety support (INS) $115,787 $115,787 $115,787 100%
IPV (NVS) $280,274 $280,274 $162,694 58%
Measles-Follow-up campaign (NVS) $103,500 $103,500
Measles-Follow-up campaign op.costs (OPC) $186,904 $186,904
Meningitis A - campaign (NVS) $1,029,500 $1,029,500 $1,048,258 102%
Meningitis A - operational costs (OPC) $829,000 $829,000 $829,000 100%
Penta (NVS) $3,637,982 $3,835,982 $3,647,312 100%
Pneumo (NVS) $3,058,967 $4,212,467 $2,942,608 96%
Rotavirus (NVS) $1,015,537 $1,559,537 $834,937 82%
Vaccine Introduction Grant (VIG) $500,000 $500,000 $500,000 100%
Yellow Fever (NVS) $557,354 $682,854 $560,207 101%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Guinea-Bissau DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 79%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2009) 82.60%
Household survey: DTP3 coverage for female (2009) 79.50%
Household survey: Last DTP3 survey (2009) 81%
% districts achieving > 80% DTP3 coverage (2017) 64%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 81%

Breakdown of support

Non-vaccine support Vaccine support
27% 73%
$3,365,266 $9,248,595

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Guinea-Bissau

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

12 November 2015

Mothers attending the launch ceremony of the PCV vaccine in Guinea Bissau, june 2015.

Unprecedented number of children protected against pneumonia with Gavi support

As the international community marks the seventh World Pneumonia Day, Gavi pneumococcal and pentavalent vaccines are reaching children at an accelerated pace.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here